$VKTX Viking Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Viking Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Viking Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Viking Therapeutics, Inc. for free.
CIK Number: 0001607678
IRS Number: 461073877
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: VKTX
Company Address: 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO 92130
Phone number: 858-704-4660
Market Capitalization: $31.36M
Prev close: $1.45
Average Daily Volume: 301,273
Days Low: $1.45
Year Low: $0.90
Year High: $2.89
Viking Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 25 2021 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | X | 1.50 | 20,000 | 30,000 | 0 | |
Mar 25 2021 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Buy | X | 1.50 | 20,000 | 30,000 | 46,250 | 26.3 K to 46.3 K (+76.19 %) |
Mar 25 2021 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | X | 1.50 | 20,000 | 30,000 | 0 | |
Mar 25 2021 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Buy | X | 1.50 | 20,000 | 30,000 | 46,250 | 26.3 K to 46.3 K (+76.19 %) |
Jan 19 2021 | VKTX | Viking Therapeutic ... | ZANTE GREG | Chief Financial Off ... | Payment of Exercise | F | 6.68 | 808 | 5,397 | 89,751 | 90.6 K to 89.8 K (-0.89 %) |
Jan 19 2021 | VKTX | Viking Therapeutic ... | Mancini Marianna | Chief Operating Off ... | Payment of Exercise | F | 6.68 | 994 | 6,640 | 169,952 | 170.9 K to 170 K (-0.58 %) |
Jan 19 2021 | VKTX | Viking Therapeutic ... | Mancini Marianna | Chief Operating Off ... | Payment of Exercise | F | 6.48 | 686 | 4,445 | 170,946 | 171.6 K to 170.9 K (-0.40 %) |
Jan 19 2021 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Payment of Exercise | F | 6.68 | 1,685 | 11,256 | 116,062 | 117.7 K to 116.1 K (-1.43 %) |
Jan 19 2021 | VKTX | Viking Therapeutic ... | Lian Brian | President & CEO | Payment of Exercise | F | 6.68 | 5,611 | 37,481 | 1,894,181 | 1.9 M to 1.9 M (-0.30 %) |
Jan 06 2021 | VKTX | Viking Therapeutic ... | Rowland Charles A Jr | Director | Option Exercise | A | 5.80 | 22,000 | 127,600 | 22,000 | |
Jan 06 2021 | VKTX | Viking Therapeutic ... | MACARTNEY LAWSON | Director | Option Exercise | A | 5.80 | 22,000 | 127,600 | 22,000 | |
Jan 06 2021 | VKTX | Viking Therapeutic ... | Rouan Sarah Kathryn | Director | Option Exercise | A | 5.80 | 22,000 | 127,600 | 22,000 | |
Jan 06 2021 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Option Exercise | A | 5.80 | 33,000 | 191,400 | 33,000 | |
Jan 06 2021 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Payment of Exercise | F | 5.80 | 2,739 | 15,886 | 117,747 | 120.5 K to 117.7 K (-2.27 %) |
Jan 06 2021 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Grant | A | 0.00 | 6,667 | 0 | 120,486 | 113.8 K to 120.5 K (+5.86 %) |